7 news items
Gritstone bio to Participate in Upcoming Investor and Scientific Conferences
GRTS
4 Jun 24
vaccines. We leverage our innovative vectors and payloads to train multiple arms of the immune system to attack critical disease targets
Gritstone bio Reports First Quarter 2024 Financial Results and Provides Corporate Updates
GRTS
9 May 24
to train multiple arms of the immune system to attack critical disease targets. Independently and with our collaborators, we are advancing a portfolio
Gritstone bio Announces Appointment of Stephen Webster to its Board of Directors
GRTS
29 Apr 24
. We leverage our innovative vectors and payloads to train multiple arms of the immune system to attack critical disease targets. Independently
Gritstone bio to Participate in Upcoming Investor and Scientific Conferences
GRTS
8 Apr 24
to train multiple arms of the immune system to attack critical disease targets. Independently and with our collaborators, we are advancing a portfolio
Gritstone bio Announces Pricing of $32.5 Million Underwritten Public Offering
GRTS
1 Apr 24
innovative vectors and payloads to train multiple arms of the immune system to attack critical disease targets. Independently and with our collaborators, we
9806wo71lo1cjplfz0fr19pqvcnc m3q6atejfvdvivf1n74fvb
GRTS
1 Apr 24
to train multiple arms of the immune system to attack critical disease targets. Independently and with our collaborators, we are advancing a portfolio
un2grtw40se46supel9522
GRTS
1 Apr 24
that aims to develop the world's most potent vaccines. We leverage our innovative vectors and payloads to train multiple arms of the immune system to attack
- Prev
- 1
- Next